Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Yang, Fei ^a   Li, Minhua ^a   Ye, Bo ^a   Zhang, Yuxia ^a   Chen, Honglei ^a   Xia, Dong ^a   Liu, Mingqiu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; BIOLOGICAL MARKER; CD30 LIGAND; HAPTOGLOBIN; PLASMA PROTEIN; PREALBUMIN; PROTEOME; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CANCER MODEL; CONTROLLED STUDY; FEMALE; LUNG CANCER; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; SERUM; TWO DIMENSIONAL ELECTROPHORESIS; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; HUMAN; LUNG TUMOR; METHODOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METHYLCHOLANTHRENE; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL;

EID: 70350110659     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/397910     Document Type: Article

References (59)

1. Qin Y., Zhou B. S., Xu Z. Y., Wu D., Inspiration of increasing trend in lung cancer morbility for investigating etiopathogenisis of lung cancer Chinese Journal of Health Statistics 2001 18 2 121 123
2. John W. T., Moulay M., Robert V., Transthoracic needle biopsy Radiologic Clinics of North America 2000 338 2 235 266
3. Anderson N. L., Anderson N. G., Proteome and proteomics: new technologies, new concepts, and new words Electrophoresis 1998 19 11 1853 1861
4. Giorgianni S. B., Proteome analysis by two-dimensional gel electrophoresis and mass spectrometry: strengths and limitations Trends in Analytical Chemistry 2003 22 5 273 281
5. Tian H. S., Liu M. Q., Gao W. Q., Induction of lung carcinoma by intralobar bronchial instillation of iodized oil rats Chinese Medical Journal 1984 97 1 36
6. Liu M., Yu L., Shu Q., Effect of superoxide dismutase and diethyldithiocarbamate on the induction of squamous cell carcinoma of lung with methylcholanthrene in rats Chinese Journal of Oncology 1994 16 4 269 272
7. Wang D.-Z., Lin L., Chan L. L., Hong H.-S., Comparative studies of four protein preparation methods for proteomic study of the dinoflagellate Alexandrium sp. using two-dimensional electrophoresis Harmful Algae 2009 8 5 685 691
8. Li X. H., Cheng D. J., Jiang M., Expression of p53, mdm2, k- ras and PCNA gene during carcinogenesis in experimental lung cancer Cancer 2001 20 9 921 925
9. Li X. H., Liu M., Diao L., Microdissection and PCR-SSCP detected mutation and expression of p53 and K-ras gene in carcinogenesis and development of induced rat lung carcinoma Chinese Journal of Pathology 2002 31 4 331 336
10. Tan L. N., Huang J. H., Recent advances in the investigation of haptoglobin Journal of International Pathology and Clinical Medicine 2006 26 1 0043 0004
11. Friedrichs W. E., Navarijo-Ashbaugh A. L., Bowman B. H., Yang F., Expression and inflammatory regulation of haptoglobin gene in adipocytes Biochemical and Biophysical Research Communications 1995 209 1 250 256
12. Mi-Kyung O., Seon-Joo P., Nam-Joon K., In-Sook K., Short communication: protein kinase-c-delta stimulates haptoglobin secretion Journal of Biochemical and Molecular Biology 2007 40 1 130 134
13. DArmiento J., Dalal S. S., Chada K., Tissue, temporal and inducible expression pattern of haptoglobin in mice Gene 1997 195 1 19 27
14. Theilgaard-Mnch K., Jacobsen L. C., Nielsen M. J., Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation Blood 2006 108 1 353 361
15. Vormittag R., Vukovich T., Mannhalter C., Haptoglobin phenotype2-2 as a potential new risk of spontaneous venous thromboembolism Haematologia 2005 90 11 577 561
16. Larssen T. B., Rrvik J., Horn A., Biochemical and cytologic analysis of cystic contents in benign non-parasitic symptomatic hepatic cysts before and after ethanol sclerotherapy Acta Radiologica 2004 45 5 504 509
17. Helivaara M. K., Teppo A. M., Karonen S. L., Tuominen J. A., Ebeling P., Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects Diabetes, Obesity and Metabolism 2005 7 6 729 736
18. Trayhurn P., Endocrine and signalling role of adipose tissue: new perspectives on fat Acta Physiologica Scandinavica 2005 184 4 285 293 (Pubitemid 41039735)
19. Ahmed N., Oliva K. T., Barker G., Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer Proteomics 2005 5 17 4625 4636
20. Gonalves A., Esterni B., Bertucci F., Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy Oncogene 2006 25 7 981 989
21. Tolson J., Bogumil R., Brunst E., Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients Laboratory Investigation 2004 84 7 845 856
22. Bresalier R. S., Byrd J. C., Tessler D., A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer Gastroenterology 2004 127 3 741 748
23. Kwak J. Y., Ma T. Z., Yoo M. J., The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia Experimental Hematology 2004 32 9 836 842
24. Nie G. J., Zhou J. H., Li M. Y., Different proteomic research between lung squamous cell carcinoma and normal blood serum Progress in Biochemistry and Biophysics 2008 35 3 349 355
25. Costa R., Ferreira-da-Silva F., Saraiva M. J., Cardoso I., Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the kunitz protease inhibitor PLoS ONE 2008 3 8, article e2899
26. Nunes A. F., Saraiva M. J., Sousa M. M., Transthyretin knockouts are a new mouse model for increased neuropeptide Y The FASEB Journal 2006 20 1 166 168
27. Macedo B., Batista A. R., do Amaral J. B., Saraiva M. J., Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy Molecular Medicine 2007 13 11-12 584 591
28. Chen L., L L., Zhang P., Li Y., Lin J., Transthyretin Arg-83 mutation in vitreous amyloidosis Eye Science 2008 24 1 65 67
29. Meistermann H., Norris J. L., Aerni H. R., Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat Molecular and Cellular Proteomics 2006 5 10 1876 1886
30. Refai E., Dekki N., Yang S. N., Transthyretin constitutes a functional component in pancreatic -cell stimulus-secretion coupling Proceedings of the National Academy of Sciences of the United States of America 2005 102 47 17020 17025
31. Sundsten T., Eberhardson M., Gransson M., Bergsten P., The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes Proteome Science 2006 4, article 22
32. Bai X. S., Gong L. L., Zhang S. H., The relationship between transthyretin and the level of blood pressure Acta Academiae Medicinae Jiangxi 2008 48 3 40 42
33. Ihara H., Matsumoto T., Shino Y., Selective use of transthyretin and retinol-binding protein as markers in the postoperative assessment of protein nutritional status Journal of Clinical Laboratory Analysis 2003 17 1 1 5
34. Strauss D. S., Nutritional regulation of visceral markers in rat liver and cultured hepatoma cells Clinical Chemistry and Laboratory Medicine 2002 40 12 1274 1280
35. Gu J. R., Jiang H. Q., He L. P., Transthyretin (prealbumin) gene in human primary hepatic cancer Science in China B 1991 34 11 1312 1318
36. Kuesel A. C., Kroft T., Prefontaine M., Smith I. C., Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease International Journal of Cancer 1992 52 3 341 346
37. Mahlck C. G., Granvist K., Plasma prealbumin in women with epithelial ovarian carcinoma Gynecologic and Obstetric Investigation 1994 37 2 135 140
38. Zhang Z., Bast R. C. Jr., Yu Y., Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Research 2004 64 16 5882 5890
39. Kuvibidila S., Yu L., Gardner R., Velez M., Ode D., Warrier R. P., Association between increased levels of TNF-, decreased levels of prealbumin and retinol-binding protein, and disease outcome Journal of the National Medical Association 2000 92 10 485 491
40. Zhou M., Fadlelmola F. M., Cohn J. B., Skinnider B., Gascoyne R. D., Banerjee D., Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas Molecular Cancer 2008 7 12
41. Hirsch B., Hummel M., Bentink S., CD30-induced signaling is absent in Hodgkins cells but present in anaplastic large cell lymphoma cells The American Journal of Pathology 2008 172 2 510 520
42. Kusanovic J. P., Romero R., Hassan S. S., Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies Journal of Maternal-Fetal and Neonatal Medicine 2007 20 12 867 878
43. Lambropoulou M., Tamiolakis D., Venizelos I., CD30 (Ber-H2) expression by thymocytes and thymic epithelial cells during the late first and second trimester of gestation: an immunohistochemical and in situ hybridization (ISH) study Medical Science Monitor 2007 13 12 280 285
44. Kamiyama H., Kurosaki K., Kurimoto M., Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers Cancer Science 2004 95 12 990 998
45. Wright C. W., Rumble J. M., Duckett C. S., CD30 activates both the canonical and alternative NF- B pathways in anaplastic large cell lymphoma cells The Journal of Biological Chemistry 2007 282 14 10252 10262
46. Gerli R., Muscat C., Bistoni O., High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints Clinical and Experimental Immunology 1995 102 3 547 550
47. Monsalve-de Castillo F., Romero T. A., Estvez J., Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases Clinical and Diagnostic Laboratory Immunology 2002 9 6 1372 1375
48. Monsalve C F., Romero-A T., Estvez J., Costa L., Callejas D., Serum levels of soluble CD30 molecule in hepatitis B virus infection Revista Medica de Chile 2001 129 11 1248 1252
49. Gilffillan M. C., Noel P. J., Podack E. R., Reiner S. L., Thompson C. B., Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines Journal of Immunology 1998 160 5 2180 2187
50. Hargreaves P. G., Al-Shamkhani A., Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30 European Journal of Immunology 2002 32 1 163 173
51. Chen G., Gharib T. G., Huang C. C., Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors Clinical Cancer Research 2002 8 7 2298 2305
52. Brichory F., Beer D., Le Naour F., Giordano T., Hanash S., Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer Cancer Research 2001 61 21 7908 7912
53. Chatterji B., Borlak J., Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers Proteomics 2007 7 21 3980 3991
54. Li C., Xiao Z. Q., Chen Z., Proteome analysis of human lung squamous carcinoma Proteomics 2006 6 2 547 558
55. Yang F., Xiao Z. Q., Zhang X. Z., Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis Journal of Proteome Research 2007 6 2 751 758
56. Lisa Z., Jamshedur R., Pinar Y., Truncation forms of serum amyloid A contribute to a serum proteomic signature of lung cancer 46 Proceedings of the American Association of Cancer Research 2005
57. Luo X. Y., Chen H. Q., Zhou J. H., Proteomic patterns in serum of lung adenocarcinoma patients and its correlation with clinical TNM stage Chinese Journal of Thoracic and Cardiovascular Surgery 2006 22 2 112 114
58. Liao P., Wang W. J., Zhu P. Y., Detection of serum protein biomarkers by surface-enhanced laser desorption and ionization time of flight mass spectrometry(SELDI-TOF-MS) in patients with lung adenocarcinoma J China Tumor 2006 15 4 258 261
59. Koomen J. M., Haura E. B., Bepler G., Proteomic contributions to personalized cancer care Molecular and Cellular Proteomics 2008 7 10 1780 1794